ATTILI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.079
AS - Asia 444
EU - Europa 240
AF - Africa 108
SA - Sud America 84
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.967
Nazione #
US - Stati Uniti d'America 1.040
SG - Singapore 195
CN - Cina 66
IT - Italia 56
BR - Brasile 49
HK - Hong Kong 37
VN - Vietnam 29
SE - Svezia 25
DE - Germania 20
FI - Finlandia 18
IN - India 17
RU - Federazione Russa 13
FR - Francia 12
PL - Polonia 12
NL - Olanda 11
DZ - Algeria 8
GB - Regno Unito 8
AO - Angola 7
AR - Argentina 7
IQ - Iraq 7
AZ - Azerbaigian 6
ES - Italia 6
GH - Ghana 6
ID - Indonesia 6
LB - Libano 6
LC - Santa Lucia 6
PY - Paraguay 6
TR - Turchia 6
BF - Burkina Faso 5
BG - Bulgaria 5
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 5
IL - Israele 5
MA - Marocco 5
MG - Madagascar 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BA - Bosnia-Erzegovina 4
CA - Canada 4
CL - Cile 4
CM - Camerun 4
PE - Perù 4
PH - Filippine 4
RW - Ruanda 4
TJ - Tagikistan 4
UZ - Uzbekistan 4
VE - Venezuela 4
ZM - Zambia 4
AM - Armenia 3
AU - Australia 3
BD - Bangladesh 3
BZ - Belize 3
CY - Cipro 3
DM - Dominica 3
GM - Gambi 3
GN - Guinea 3
GP - Guadalupe 3
IR - Iran 3
JM - Giamaica 3
LU - Lussemburgo 3
ME - Montenegro 3
MU - Mauritius 3
MZ - Mozambico 3
SA - Arabia Saudita 3
SD - Sudan 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
UG - Uganda 3
UY - Uruguay 3
YT - Mayotte 3
ZA - Sudafrica 3
AD - Andorra 2
BE - Belgio 2
BJ - Benin 2
BO - Bolivia 2
CG - Congo 2
CH - Svizzera 2
CO - Colombia 2
CW - ???statistics.table.value.countryCode.CW??? 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
GF - Guiana Francese 2
GT - Guatemala 2
HT - Haiti 2
IE - Irlanda 2
IS - Islanda 2
KE - Kenya 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
MN - Mongolia 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
Totale 1.902
Città #
Fairfield 177
Ashburn 140
Singapore 111
Chandler 91
Woodbridge 85
Seattle 63
Houston 61
Cambridge 59
Wilmington 53
Santa Clara 39
Ann Arbor 37
Hong Kong 35
Beijing 25
Boardman 17
San Diego 14
New York 13
Medford 12
Princeton 12
Helsinki 11
Padova 11
Roxbury 11
Ho Chi Minh City 10
Chicago 9
Los Angeles 9
Bytom 8
Des Moines 7
Hanoi 7
Pune 7
Castries 6
Abidjan 5
Antananarivo 5
Baku 5
Lappeenranta 5
Redondo Beach 5
Accra 4
Dushanbe 4
Hefei 4
Kigali 4
Luanda 4
Lusaka 4
Munich 4
Nuremberg 4
Ouagadougou 4
Pignone 4
Tashkent 4
Biên Hòa 3
Brooklyn 3
Chennai 3
Conakry 3
Frankfurt am Main 3
Guangzhou 3
Kampala 3
London 3
Luxembourg 3
Milan 3
Montreal 3
Nanchang 3
Podgorica 3
Roseau 3
San Francisco 3
Santiago 3
Yerevan 3
Addis Ababa 2
Amsterdam 2
Andorra la Vella 2
Apia 2
Asunción 2
Atlanta 2
Baghdad 2
Banjul 2
Bauru 2
Bắc Giang 2
Cape Town 2
Cerro al Lambro 2
Charlotte 2
Ciudad del Este 2
Constantine 2
Cotonou 2
Damascus 2
Dublin 2
Duque de Caxias 2
Elk Grove Village 2
Falkenstein 2
Grisignano di Zocco 2
Guarulhos 2
Istanbul 2
Johor Bahru 2
Lahore 2
Lima 2
Milazzo 2
Montevideo 2
Nicosia 2
Oujda 2
Panama City 2
Phnom Penh 2
Port Moresby 2
Porto Alegre 2
Prague 2
Rio de Janeiro 2
Rome 2
Totale 1.336
Nome #
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes 223
Immunotherapy in small-cell lung cancer: From molecular promises to clinical challenges 204
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 199
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors 190
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 175
Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy 165
Therapeutic approaches for T790M mutation positive non-small-cell lung cancer 148
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 148
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer 144
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs? 143
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 129
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer 125
Totale 1.993
Categoria #
all - tutte 6.368
article - articoli 6.368
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 9 37 54 16 28 41 14 33
2021/2022220 20 18 14 10 26 21 24 11 24 4 13 35
2022/2023132 21 20 7 22 24 13 0 8 10 3 3 1
2023/202492 5 15 7 12 3 21 0 10 5 2 5 7
2024/2025340 2 44 12 22 46 14 8 41 19 8 51 73
2025/2026681 70 93 146 243 129 0 0 0 0 0 0 0
Totale 1.993